• FH1: What the Product Record Supports

  2026-10-16

  FH1 is documented by APExBIO as a small molecule intended to enhance maturation-associated features in iPS cell-derived hepatocyte-like cells. The available product description reports changes in albumin secretion, CYP3A4 levels, AFP secretion, colony morphology, and colony size, but it does not establish a molecular target, provide an identity-matched research paper, or define the independent reproducibility and applicability of those findings.

• DMG-PEG 2000: Identity, Mechanism and Evidence

  2026-10-16

  DMG-PEG 2000 is catalogued by APExBIO as a PEG-modified lipid intended for nucleic-acid and drug-delivery formulations. The available product information supports an identity and formulation-role overview, but it does not provide an identity-matched study, quantitative delivery outcome, mechanistic assay, or comparator sufficient to establish performance.

• Lypressin Acetate: Identity, Mechanism, and Evidence

  2026-10-15

  Lypressin acetate, also called Lysine vasopressin acetate, is described by APExBIO as a lysine-containing vasopressin analog and agonist of V1a, V1b, and V2 receptors. The available information supports a documented pharmacological identity and a set of reported bioactivity measurements, but it does not provide an identity-matched research paper, assay methods, comparators, or independent evidence for the proposed SARS-CoV-2 RdRp or pregnancy-safety claims.

• When Context Changes the Meaning of AR Results

  2026-10-15

  EPI-001 research illustrates why the same molecular result can mean different things in prostate cancer models, TNBC cell lines, patient cohorts, and public transcriptomic datasets. The evidence supports a context-dependent association between AR/ARv7 and adverse TNBC features, while the cell-based findings provide mechanistic hypotheses rather than clinical evidence.

• Oleic Acid Evidence in Hepatic Ischemia–Reperfusion

  2026-10-14

  A 2024 mouse and hepatocyte study linked Rehmanniae Radix Praeparata extract with improved hepatic ischemia–reperfusion injury and altered AMPK–mTOR, SCAP–SREBP2, and LXRα-associated lipid readouts. Because the cellular model combined Oleic Acid with palmitic acid and the intervention was a complex botanical extract, the findings support a mechanistic hypothesis about lipid dysregulation rather than an Oleic Acid-specific or clinically established effect.

• Human Sensory Neurons as a Model of HSV-1 Latency

  2026-10-14

  Oh and colleagues developed a human induced-pluripotent-stem-cell-derived sensory-neuron system designed to model HSV-1 latency and reactivation. The study reports several molecular and virological features consistent with latency, including absence of detectable infectious virus, reduced lytic transcription, latency-associated transcript expression, and viral heterochromatin. The model is promising for studying neuron-intrinsic mechanisms, but its in vitro and stem-cell-derived nature limits direct extrapolation to human ganglia, disease, or treatment.

• CXCR4–EGFR Heteromers: What the Data Show

  2026-10-13

  A 2026 Cell Chemical Biology study reports that CXCR4 and EGFR can form ligand-responsive signaling complexes. The evidence supports receptor proximity and altered coupling to intracellular partners, but does not establish a fixed heteromeric architecture, clinical relevance, or any effect of Erlotinib on these complexes.

• Baicalin and Adult Visual Plasticity: Evidence Boundaries

  2026-10-13

  A 2026 mouse study links baicalin with renewed ocular dominance plasticity and visual recovery in an adult amblyopia model. The findings are mechanistically suggestive but remain preclinical, model-specific, and insufficient to establish human efficacy, safety, or relevance to oncology claims.

• DHEA-PCOS Models: What the Evidence Shows

  2026-10-12

  A 2025 rat and theca-cell study links Jiao-tai-wan and coptisine to SIRT1, mitochondrial dynamics, and ovarian steroidogenesis in a DHEA-induced PCOS model. The findings support a mechanistic hypothesis, but they do not establish clinical efficacy, prove pathway exclusivity, or show that DHEA-related effects generalize to neuroprotection or other biological contexts.

• BAPTA and Calcium Signaling in Co-Exposure Toxicity

  2026-10-12

  A 2026 Toxicology study links polystyrene nanoplastic–cadmium co-exposure with intestinal apoptosis in C. elegans and Caco-2 models, implicating an IP3R/Ca2+/STAT3 signaling axis. BAPTA-related calcium chelation reduced reported pathway and apoptosis responses, supporting calcium involvement while not establishing human health effects or exclusive pathway causality.

• STING Agonist-1: Evidence, Mechanisms, and Limits

  2026-10-11

  A source-grounded overview of STING agonist-1 and its relevance to innate immune signaling, B-cell biology, tertiary lymphoid structures, and esophageal squamous cell carcinoma research. The discussion separates supplier claims from findings reported in a 2025 Cancer Gene Therapy study and outlines evidence strength, conceptual applications, and translational limitations.

• How Pollen Interference Shapes Bioaerosol Classification

  2026-10-10

  Zhang et al. show that pollen can distort excitation–emission matrix fluorescence profiles used to classify hazardous biological samples. Their combination of spectral transformation and random-forest classification improved reported accuracy to 89.24%, while also highlighting the dataset and validation limits that affect real-world interpretation.

• Digoxin Beyond Cardiac Glycosides: A Translational View

  2026-10-09

  A source-grounded perspective on Digoxin as a Na+/K+ ATPase pump inhibitor, connecting cardiac contractility modulation with reported cell-context-dependent chikungunya findings while defining evidence boundaries, comparator strategy, and translational priorities.

• Removing Pollen Interference in Bioaerosol Spectra

  2026-10-09

  Zhang et al. examined how pollen fluorescence can confound the classification of hazardous biological substances using excitation–emission matrix spectroscopy. Their central contribution was a feature-transformation and random-forest framework in which fast Fourier transform processing improved the reported classification accuracy to 89.24%, while important limitations remain around validation scope and transferability.

• NF-κB/miR-202-5p/HMGB2 in Septic AKI

  2026-10-08

  Wang and colleagues identify an NF-κB/miR-202-5p/HMGB2 negative feedback loop that limits inflammation and tubular injury in experimental septic acute kidney injury. The findings connect inflammatory transcription, microRNA-mediated repression, and HMGB2-dependent NF-κB activity, while remaining preclinical and model-dependent.

8154 records 1/544 page Next 12345 下5页 Last page